Trial Profile
A randomised,double-blind,placebo controlled study assessing pharmacokinetics and pharmacodynamics of intrathecally administered Xen2174 in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jan 2017
Price :
$35
*
At a glance
- Drugs XEN 2174 (Primary)
- Indications Pain
- Focus Pharmacodynamics; Pharmacokinetics
- 07 Jan 2017 New trial record